Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 10/20 | 0.62 |
| ▸ | MAPT | P10636 | 4/20 | 0.62 |
| ▸ | MEN1 | O00255 | 3/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.62 |
| ▸ | HPGD | P15428 | 2/20 | 0.62 |
| ▸ | HTT | P42858 | 2/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | RECQL | P46063 | 1/20 | 0.62 |
| ▸ | BLM | P54132 | 1/20 | 0.62 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.62 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.62 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29567328 | 1.00 | FTO (0.62) | FTOMAPTMEN1KMT2AHPGD | |
| Benzene SCHEMBL28075802 | 0.99 | FTO (0.60) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL29449527 | 0.98 | FTO (0.62) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL28250997 | 0.98 | FTO (0.62) | FTOMAPTMEN1KMT2AHPGD | |
| Isothiocyanate SCHEMBL28223712 | 0.97 | FTO (0.58) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL71426 | 0.93 | FTO (0.64) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL29354242 | 0.93 | FTO (0.64) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL30103772 | 0.93 | FTO (0.64) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL29838684 | 0.93 | FTO (0.64) | FTOMAPTMEN1KMT2AHPGD | |
| Dimethylformamide SCHEMBL28075081 | 0.93 | FTO (0.54) | FTOMAPTMEN1KMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 580 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12402638-B2 | Materials and methods for extending shelf-life of foods | JP LABORATORIES, INC. (US) | 2025-09-02 | — | — | US | claimed |
| EP-4590340-A1 | POLYMERS WITH STEROIDS OR VITAMINS | Sony Group Corporation (JP) | 2025-07-30 | — | — | EP | claimed |
| EP-4577823-A2 | COMPOSITIONS AND METHODS FOR SINGLE WELL MULTIPLEXED CALIBRATION AND COMPENSATION | Slingshot Biosciences, Inc. (US) | 2025-07-02 | — | — | EP | claimed |
| US-20250194617-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-06-19 | — | — | US | claimed |
| US-12332241-B2 | Apoptotic cell mimic | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-06-17 | — | — | US | claimed |
| US-20250189428-A1 | COMPOSITIONS AND METHODS FOR SINGLE WELL MULTIPLEXED CALIBRATION AND COMPENSATION | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-06-12 | — | — | US | claimed |
| US-20250169514-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-05-29 | — | — | US | claimed |
| CN-119997980-A | Polymers with steroids or vitamins | 索尼集团公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119744345-A | Compositions and methods for single well multiple calibration and compensation | 弹弓生物科学公司 | 2025-04-01 | — | — | CN | claimed |
| WO-2025049609-A1 | CD34 STEM CELL MIMICS | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-03-06 | — | — | WO | claimed |
| US-20050112569-A1 | Method of determining blood-relationship by typing str alleles on the x chromosome and dna typing kit using the same | I.D. GENE, INC. (KR) | 2005-05-26 | — | — | US | claimed |
| US-20040214199-A1 | Triphosphate oligonucleotide modification reagents and uses thereof | AUDAX PRIVATE DEBT LLC, AS AGENT | 2004-10-28 | — | — | US | claimed |
| EP-1305327-A2 | TRIPHOSPHATE OLIGONUCLEOTIDE MODIFICATION REAGENTS AND USES THEREOF | Schwartz, David A. (US) | 2003-05-02 | — | — | EP | claimed |
| EP-0673392-B1 | METHOD OF PREFERENTIAL LABELLING OF PHYCOBILIPROTEIN WITH AMINE-REACTIVE DYE FOR USE IN A MULTIPLE COLOR ASSAY | COULTER INT CORP (US) | 2003-04-02 | — | — | EP | claimed |
| US-6512580-B1 | Microplate comprising base layered with porous substrate having absorbed dry light emissive compound so that liquid sample permeates substrate and reacts with compound and with incident radiation, emitting radiation for analysis | VERIFICATION TECHNOLOGIES, INC. | 2003-01-28 | — | — | US | claimed |
| WO-2002010432-A2 | TRIPHOSPHATE OLIGONUCLEOTIDE MODIFICATION REAGENTS AND USES THEREOF | SCHWARTZ DAVID A (US) | 2002-02-07 | — | — | WO | claimed |
| EP-0745602-A1 | Quinidine immunoassay and reagents | F. HOFFMANN-LA ROCHE AG (CH) | 1996-12-04 | — | — | EP | claimed |
| EP-0233053-B1 | Method of detecting electrophoretically separated oligonucleotides | APPLIED BIOSYSTEMS (US) | 1994-06-01 | — | — | EP | claimed |
| US-4855225-A | LABELING WITH FLUORESCENT OR RHODANINE DYES | APPLIED BIOSYSTEMS, INC. (US) | 1989-08-08 | — | — | US | claimed |
| EP-0233053-A2 | Method of detecting electrophoretically separated oligonucleotides | APPLIED BIOSYSTEMS, INC. (US) | 1987-08-19 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040214199-A1 | Triphosphate oligonucleotide modification reagents and uses thereof | RNGTT, DUT, NUDT1 | FTO 307/4885MAPT 4128/4885MEN1 4429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.